Health Canada has amended the license for HEXO Corp.’s cannabis manufacturing and processing facility in Belleville, Ontario, for the sale of dried and fresh cannabis, cannabis extracts, cannabis topicals and edible cannabis products. The amendment also includes a beverage production area dedicated to the Truss/HEXO beverage division.
“Receiving the sales license for our Belleville facility is extremely positive news for HEXO and Truss, our joint-venture with Molson Coors Canada,” said Sebastien St-Louis, CEO and co-founder of HEXO. “This license allows us to increase our processing capability significantly, achieve greater economies of scale, and continue to roll out more innovative 2.0 products across all of our brands Powered by HEXOTM, including hash, vapes, cannabis beverages, and other edible cannabis products.”
The Belleville facility will act as the main development, processing and distribution facility for HEXO’s cannabis products. Located along primary shipping routes in Ontario, the facility further delivers on HEXO’s national expansion strategy and ensures necessary capacity for the manufacturing and distribution of advanced cannabis products to fulfil purchase orders across the country.
“HEXO’s Belleville facility is a purpose-built manufacturing center,” St-Louis said. “By using specifically designed automation and best-in-class cannabis technology to streamline our processes, we are focusing on long-term cost reductions and improvements to our portfolio wide gross margin.”